US FDA Updates Policy For Adding Cleared Assays To Additional Instruments
Executive Summary
Under a draft guidance, IVD manufacturers wouldn’t need to submit a new 510(k) if they were clearing an assay for use with an instrument similar to those it was already cleared on.